These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28032956)

  • 21. Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.
    Syed I; Sunkaraneni VS
    J Laryngol Otol; 2015 May; 129(5):410-5. PubMed ID: 25736077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.
    Yaniv E; Preis M; Shevro J; Nageris B; Hadar T
    Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid.
    Saba HI; Morelli GA; Logrono LA
    N Engl J Med; 1994 Jun; 330(25):1789-90. PubMed ID: 8190155
    [No Abstract]   [Full Text] [Related]  

  • 24. Purpose-built septal splints for control of hereditary haemorrhagic telangiectasia related epistaxis: A prospective study.
    Brahmabhatt P; Mankunda Puttasiddaiah P; Hollisey-Mclean S; Bruce Whittet H
    Clin Otolaryngol; 2021 Jul; 46(4):911-914. PubMed ID: 33735539
    [No Abstract]   [Full Text] [Related]  

  • 25. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
    Klepfish A; Berrebi A; Schattner A
    Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
    [No Abstract]   [Full Text] [Related]  

  • 26. Propanolol and angiogenesis inhibition in hereditary haemorrhagic telangiectasia.
    Breier G
    Thromb Haemost; 2012 Jul; 108(1):1-2. PubMed ID: 22628061
    [No Abstract]   [Full Text] [Related]  

  • 27. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.
    Albiñana V; Recio-Poveda L; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2012 Jul; 108(1):41-53. PubMed ID: 22552254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis.
    Chitsuthipakorn W; Hoang MP; Kanjanawasee D; Seresirikachorn K; Snidvongs K
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):689-701. PubMed ID: 37995018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tranexamic acid in hereditary hemorrhagic telangiectasia.
    Lozano M
    N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543
    [No Abstract]   [Full Text] [Related]  

  • 30. The therapeutic efficacy of propranolol in children with recurrent primary epistaxis.
    Bjelakovic B; Bojanovic M; Lukic S; Saranac L; Vukomanovic V; Prijic S; Zivkovic N; Randjelovic D
    Drug Des Devel Ther; 2013; 7():127-9. PubMed ID: 23467483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases.
    McCaffrey TV; Kern EB; Lake CF
    Arch Otolaryngol; 1977 Nov; 103(11):627-30. PubMed ID: 921594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary haemorrhagic telangiectasia: Young's procedure in the management of epistaxis.
    Hosni AA; Innes AJ
    J Laryngol Otol; 1994 Sep; 108(9):754-7. PubMed ID: 7964136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemorrhagic telangiectasia.
    Ananthasubramaniam G; Sathyavathi R; Chitra N
    J Assoc Physicians India; 1981 May; 29(5):425-7. PubMed ID: 7298565
    [No Abstract]   [Full Text] [Related]  

  • 37. Retrospective analysis of submucosal radiofrequency procedure for the treatment of nasal bleeding in 44 patients with hereditary haemorrhagic telangiectasia.
    Hochet B; Achard S; Maillard H; Mortuaire G
    Clin Otolaryngol; 2019 Nov; 44(6):1138-1141. PubMed ID: 31433905
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
    Yaniv E; Preis M; Hadar T; Shvero J; Haddad M
    Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The natural history of epistaxis in hereditary hemorrhagic telangiectasia.
    AAssar OS; Friedman CM; White RI
    Laryngoscope; 1991 Sep; 101(9):977-80. PubMed ID: 1886446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.